HIMSNYSEServices-Offices & Clinics of Doctors of MedicineUS GAAP · USD

Hims & Hers Health, Inc.

Hims & Hers Health, Inc. runs a consumer-first digital health platform that connects patients to licensed clinicians, online prescriptions, and pharmacy fulfillment. Founded in 2017, it focuses on routine and recurring care areas such as sexual health, hair loss, hormone health, weight loss, dermatology, mental health, and lab testing, delivered through its websites and mobile apps.

Revenue2,348m USD
+59.0 %y/y
Operating profit (EBIT)106m USD
+70.6 %y/y
EBIT margin4.5%
+0.3 ppy/y
Net income128m USD
+1.8 %y/y
Free cash flow300m USD
+19.5 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-50005001,0001,5002,0002,500m USD2020: 149 m USD2020: EBIT -15 m USD20202021: 272 m USD2021: EBIT -115 m USD20212022: 527 m USD2022: EBIT -69 m USD20222023: 872 m USD2023: EBIT -29 m USD20232024: 1,477 m USD2024: EBIT 62 m USD20242025: 2,348 m USD2025: EBIT 106 m USD20252,348106
RevenueOperating profit (EBIT)

Business

Share of revenue
Prescription telehealth treatments70 %

Condition-specific online consultations, clinician visits, and prescription therapies fulfilled through the platform.

Non-prescription wellness products10 %

Over-the-counter and wellness products sold directly to consumers through digital and retail channels.

Laboratory testing and diagnostics8 %

At-home or facilitated lab testing used to support diagnosis, treatment selection, and follow-up care.

Pharmacy and fulfillment services7 %

Cloud-enabled dispensing, packaging, and shipping services that support recurring treatment delivery.

Platform access and care services5 %

Digital care infrastructure, follow-up support, and app-based health content that improve retention and engagement.

Customers

The company sells directly to consumers who want convenient, private, and lower-friction access to care for sensitive or recurring conditions. Its core users are people seeking treatment for the first time or looking for ongoing subscription-based care in areas where stigma, access barriers, or convenience matter. It also reaches shoppers for non-prescription wellness products, including through retail locations in the United States.

Direct-to-consumer prescription patients

Buy clinician-guided prescription treatments for sexual health, hair loss, weight loss, dermatology, hormone health, and mental health because the platform is private and convenient.

Subscription-based recurring care users

Purchase ongoing treatment plans and refills through the app because the model supports continuity, follow-up, and convenience.

Non-prescription wellness shoppers

Buy over-the-counter health and wellness products for self-directed care and everyday maintenance.

Lab testing and diagnostics users

Order testing to support diagnosis, treatment selection, and monitoring for conditions managed on the platform.

Retail channel consumers

Purchase non-prescription products in U.S. retail locations, extending the brand beyond the app ecosystem.

Strategy

The company is focused on expanding customer acquisition, increasing cross-sell within its existing base, and broadening the number of conditions it can treat. It is also investing in marketing infrastructure, technology, and clinical capabilities to make the platform more personalized and easier to use, while recent acquisitions point to a longer-term push into adjacent digital health capabilities and geographies.

Customer acquisition at scaleShort term

Growth depends on continuously bringing new users onto the platform at acceptable marketing returns.

Expand within the existing customer baseMedium term

Cross-sell and subscription retention improve lifetime value and reduce reliance on new-user growth.

Broaden clinical and product capabilitiesMedium term

More conditions and services increase platform relevance and make the brand harder to replace.

Selective acquisitions and international expansionLong term

Acquired platforms and new geographies can add users, capabilities, and long-term revenue pools.

Geography

Q1/2026

Hims & Hers serves customers in the United States, Canada, the United Kingdom, and parts of the European Union, including Germany, Ireland, France, and Spain. The business is still centered on the U.S., but its recent acquisitions and international platform expansion suggest a broader multi-country footprint over time. Geography matters because healthcare regulation, pharmacy operations, and telehealth rules differ by market and affect how quickly the company can scale.

United States87 %
Other countries (US filing)13 %

Share of the revenue the company reports by geography.

Risks

The business depends heavily on digital marketing efficiency, platform trust, and the ability to retain customers in a highly regulated healthcare environment. Cybersecurity, privacy, pharmacy operations, compounding, and changing telehealth or drug regulations are especially important because the model handles sensitive patient data and prescription fulfillment online.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Cybersecurity and data privacy breaches1Marketing inefficiency and customer acquisition slowdown2Regulatory changes affecting telehealth, prescriptions, and compounding3Competition from digital health, pharmacies, and traditional providers4Execution risk from acquisitions and international expansion5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Cybersecurity and data privacy breachesImpact: HighLikelihood: Medium

    The platform stores and transmits sensitive patient information and relies on third parties for key functions.

    ExposureCustomer and patient dataCloud systemsVendor infrastructure
  2. Marketing inefficiency and customer acquisition slowdownImpact: HighLikelihood: Medium

    Revenue depends on continuously enrolling new customers at acceptable returns on marketing spend.

    Exposure: Direct-to-consumer demand generation

  3. Regulatory changes affecting telehealth, prescriptions, and compoundingImpact: HighLikelihood: Medium

    The company operates in a heavily regulated healthcare and pharmaceutical environment.

    ExposureFDA rulesState and federal telehealth lawsPharmacy operations
  4. Competition from digital health, pharmacies, and traditional providersImpact: MediumLikelihood: Medium

    The company competes against both niche digital rivals and larger healthcare organizations.

    ExposureSexual healthWeight lossDermatologyMental healthLab testing
  5. Execution risk from acquisitions and international expansionImpact: MediumLikelihood: Medium

    New platforms and geographies can increase operating complexity before benefits are realized.

    ExposureIntegrationComplianceOperating expense growth

Accounting

Judgemental items
Revenue recognition for subscription prescriptions and services

The company derives a substantial majority of revenue from subscription-based purchases, so timing and fulfillment patterns matter.

Impact: Quarterly revenue comparability and deferred revenue balances

Inventory valuation

Pharmacy fulfillment and product sales require estimates for obsolescence and realizability.

Impact: Gross margin and inventory write-down risk

Stock-based compensation

A growing consumer platform often uses equity awards to attract and retain talent.

Impact: Operating expenses and diluted share count

Business combination fair values and contingent consideration

Recent acquisitions introduce earn-outs and purchase accounting judgments.

Impact: Goodwill, intangible assets, and future expense volatility

Lease and cloud software commitments

The company has operating leases and non-cancelable purchase obligations tied to operations.

Impact: Fixed obligations and cash flow visibility

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Hims & Hers Health, Inc. (HIMS) Revenue, Earnings & Financials 2025 – Clarifo